Infections with human papillomavirus (HPV) are common and transmitted by direct contact.
Although the great majority of infections resolve within 2 years, 13 phylogenetically related …

The discovery of genotype 16 as the prototype oncogenic human papillomavirus (HPV)
initiated a quarter century of laboratory and epidemiological studies that demonstrated their …

Background Assessing the duration of immunity following infection with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is a first priority to gauge the degree of …

Human papillomaviruses (HPVs) are the causative agent of several anogenital cancers as
well as head and neck cancers, with HPV+ head and neck squamous cell carcinoma …

Background Human papillomavirus (HPV) infects and propagates in the cervical mucosal
epithelium. Hence, in addition to assessing systemic immunity, the accurate measurement of …

Two of the most important human oncogenic viruses are hepatitis B virus (HBV) and human
papillomavirus (HPV). HBV infection has been preventable by vaccination since 1982; …

Benign and malignant disease caused by HPV (human papillomavirus) constitutes a global
public health problem. Genital warts are the commonest viral sexually transmitted infection …

Avidity of immunoglobulin G (IgG) is defined as its binding strength to its target antigen. As a
consequence of affinity maturation of the IgG response, avidity is maturing as well …

Although licensed human papillomavirus (HPV) vaccines are most efficacious in persons
never infected with HPV, they also reduce infection and disease in previously infected …

Introduction Current human papillomavirus (HPV) vaccines consist of virus-like particles
(VLPs) which are based on the L1 protein, but they are produced by different expression …